Junior doctors’ strike: NHS chief warns of tough new year
A planned six-day junior doctors’ strike will have a big impact on routine care, a health chief says.
Similar Posts
Bayer’s new CEO plans to cut management jobs in prelude to overhaul | Reuters News Agency
Business & FinanceHealth 15 September 2023, 1:53 pm 1 minute Reuters exclusively reported that Bayer’s (BAYGn.DE) new CEO plans to cut management jobs to speed up decision-making as a first step to overhaul the embattled German industrial group, which is facing investor pressure to break up. Market Impact Anderson has been tasked with reviving Bayer’s…
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker could market five products by 2026. The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot. The company’s stock…
Some nurses experience violent attacks at Seattle Children’s Hospital, say they want protection, support
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
COVID infections on the rise as new year begins
COVID infections on the rise as new year begins – CBS News Watch CBS News A rise in COVID-19 infections has prompted at least five states to reinstate mask requirements at health care facilities. Elise Preston reports. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now…
If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to themselves. But given the potential size of this opportunity, which some have put at more than $100 billion by 2030 , other pharmaceuticals companies —…
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…
